Nigel Temperton
About
Nigel Temperton is from Chatham, England, United Kingdom. Nigel works in the following industries: "Biotechnology Research". Nigel is currently Reader at University of Kent, located in Medway, England, United Kingdom. Nigel also works as Consultant at VisMederi srl, a job Nigel has held since Jul 2020. Another title Nigel currently holds is Scientific Advisor at DIOSVax. In Nigel's previous role as a Principal Investigator at MRC/UCL Centre for Medical Molecular Biology, Nigel worked in until Sep 2009. Prior to joining MRC/UCL Centre for Medical Molecular Biology, Nigel was a Senior Post-doctoral Research Fellow at University College London and held the position of Senior Post-doctoral Research Fellow. Prior to that, Nigel was a Post-doctoral Research Fellow at UCL Medical School, Royal Free Campus from Jan 2002 to Dec 2002. Nigel started working as Laboratory Research Manager at UCL Medical School, Royal Free Campus in Jan 1999.
Go to finalscout.com and type Nigel Temperton's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Nigel Temperton's current jobs
External examiner for BSc Integrative Biomedical Sciences Dual Award programme at Zhejiang University-University of Edinburgh Institute, Haining, China
The main aim of Project FIT is to build a sustainable world-class Nanotechnology for Healthcare Centre in Central Europe based on novel recombinant vaccine, molecular adjuvant and modern drug delivery technologies. http://www.fit-vri.com/en/
Pseudovirus serologics and pharmacologics
Nigel Temperton's past jobs
In this post my research was focused primarily on humoral immunity to influenza virus, with emphasis on the H5N1 subtype strains. Other research activities included study of the antibody response to SARS-CoV, rabies/lyssaviruses and emerging flaviviruses. Funded by an MRC project grant and a joint academia-industry grant with the company Ablynx from the Flemish Institute of Science and Technology (IWT).
This post was funded by a Wellcome Trust grant (human endogenous retroviruses, SARS-CoV pseudotypes) and an MRC grant (HIV and H5N1 pseudotypes).
In this post I was involved primarily in the development and pre-clinical evaluation of cytomegalovirus DNA vaccines.
I was responsible for the management of junior technical and research staff, for IT support, for health & safety within the centre, and for logistical support to the in-house Clinical Trials Centre.